Click a link below to view the mailing archive as if it had been sent to you.
| 2011-05-31 12:00 | | 7 Dividend Winners in Big Pharma and more... |
| 2011-05-31 00:00 | | Is Affymetrix's Stock a Bargain by the Numbers? and more... |
| 2011-05-30 12:00 | | The 10 Best Values in Pharma and Biotech and more... |
| 2011-05-30 00:00 | | FDA approves Teva generic HIV treatment and more... |
| 2011-05-29 00:00 | | Investment Focus : Divis Laboratories - Buy and more... |
| 2011-05-28 00:00 | | J&J Now the âÔö£é?öé??Ôö£éÔö?èBest Biotech PlayâÔö£é?öé??Ôö£éÔö¼?ÿ, Says Goldman |
| 2011-05-27 12:00 | | Cutting Up Pfizer May Just Make a Big Mess and more... |
| 2011-05-27 00:00 | | Athersys Releases Encouraging Results for Single Dose Arm of MultiStem and more... |
| 2011-05-26 12:00 | | Dynavax finishes 2,400-patient hepatitis vaccine test and more... |
| 2011-05-26 00:00 | | Sanofi Defends Effort to Block Generics Amid LawmakersâÔö£é?öé??Ôö£é?ö?ñó Inquiry and more... |
| 2011-05-25 12:00 | | NovartisâÔö£é?öé??Ôö£é?ö?ñós Gilenya MS Drug Has 10,000 Users in U.S., Mundel Says and more... |
| 2011-05-25 00:00 | | VertexâÔö£é?öé??Ôö£é?ö?ñós Sales Force Gears Up For âÔö£é?öé??Ôö£éÔòª?úDavid vs. GoliathâÔö£é?öé??Ôö£é?ö?ñó Marketing Push and more... |
| 2011-05-24 12:00 | | J&J Approved, But Needs Help From a Friend and more... |
| 2011-05-24 00:00 | | FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular D... and more... |
| 2011-05-23 00:00 | | Sangamo's Inevitable Acquisition/Merger and more... |
| 2011-05-22 00:00 | | Johnson & Johnson To Present Review of its Pharmaceutical Business and more... |
| 2011-05-21 12:00 | | One Reason the Street Should Love Novo Nordisk's Earnings and more... |
| 2011-05-21 00:00 | | Merck Serious About Growth and more... |
| 2011-05-20 12:00 | | FDA Sets Meeting Date in Early June to Discuss Re-submission of Pixantrone NDA for Accelerated Approval and more... |
| 2011-05-20 00:00 | | Botox regulations for minors pass NJ committee and more... |
| 2011-05-19 12:00 | | Teva Positioned to Acquire Spectrum Pharmaceuticals? and more... |
| 2011-05-19 00:00 | | Top 2 Pharmaceutical Stocks Set to Soar and more... |
| 2011-05-18 00:00 | | Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years and more... |
| 2011-05-17 12:00 | | SanofiâÔö£é?öé??Ôö£é?ö?ñós Genzyme Sues Allergan for Royalties on Juvederm and more... |
| 2011-05-17 00:00 | | Merck closes acquisition of eye drug maker Inspire in deal worth $430M, or $5 per share and more... |
| 2011-05-16 12:00 | | Exelixis: Looming Cancer Conference a Favorable Swing Trade Opportunity and more... |
| 2011-05-15 00:00 | | GSK, University of Manchester & AstraZeneca create Manchester Collaborative Centre for Inflammation Research and more... |
| 2011-05-14 00:00 | | Abbott's Management Is Creating Value and more... |
| 2011-05-13 12:00 | | At Teva, Bigger IsnâÔö£é?öé??Ôö£é?ö?ñót Better: Why Acquisitions Are Ruining a Once Great Company and more... |
| 2011-05-13 00:00 | | Shire eyes huge sales from new Vyvanse uses and more... |
| 2011-05-12 12:00 | | Ariad and Exelixis Look to Shine at Upcoming Trade Show and more... |
| 2011-05-12 00:00 | | Takeda Said to Be in Talks to Acquire Swiss Drugmaker Nycomed and more... |
| 2011-05-11 12:00 | | Novartis Ousts Several Senior Managers For Misconduct and more... |
| 2011-05-11 00:00 | | AllerganâÔö£é?öé??Ôö£é?ö?ñós Botox: Beyond the Vanity Market and more... |
| 2011-05-10 12:00 | | Why Is Sequenom Up 20%? and more... |
| 2011-05-10 00:00 | | Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study and more... |
| 2011-05-09 12:00 | | Novavax Q1 revenues up and more... |
| 2011-05-07 12:00 | | XOMA's CEO Discusses Q1 2011 Results - Earnings Call Transcript and more... |
| 2011-05-06 12:00 | | Medicare Overhaul Unlikely to Be Part of Budget Talks and more... |
| 2011-05-06 00:00 | | Higher-than-Expected Loss at Onyx and more... |
| 2011-05-05 12:00 | | Tomorrow Never Comes: Pfizer Says $1.5B in Savings Will Show Up âÔö£é?öé??Ôö£éÔö¼?¬ Next Year and more... |
| 2011-05-05 00:00 | | Cell Therapeutics: Denied but Not Rejected and more... |
| 2011-05-04 12:00 | | Charles River Labs 1st-quarter profit surges on sale of early-stage business, but revenue dips and more... |
| 2011-05-04 00:00 | | Xoma botulism treatment starts early-stage government trial and more... |
| 2011-05-03 12:00 | | Cell Therapeutics gets pixantrone news from FDA office and more... |
| 2011-05-03 00:00 | | Lilly, Boehringer Win FDA Approval for Type 2 Diabetes Drug and more... |
| 2011-05-02 12:00 | | Following Heavy Trading Action, Avanir Could Be Shaping Up for Quite the Week and more... |
| 2011-05-02 00:00 | | Is Teva's Stock a Bargain by the Numbers? and more... |
